Endothelial dysfunction and restenosis following percutaneous coronary intervention

被引:24
作者
Thanyasiri, Panuratn
Kathir, Krishna
Celermajer, David S.
Adams, Mark R. [1 ]
机构
[1] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW 2050, Australia
关键词
Coronary intervention; Restenosis; Nitric oxide; Endothelium;
D O I
10.1016/j.ijcard.2006.08.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Restenosis remains an important limitation of PCI. Although local factors such as small vessel diameter and systemic factors such as diabetes explain some of its incidence, it nevertheless also occurs in low-risk patients. We hypothesize that endothelial dysfunction may be an independent risk factor in some of these cases. Methods: 20 patients who had previously undergone PCI were studied at cardiac catheterization (10 with restenotic lesions were matched to 10 without restenosis). Infusion of multiple concentrations of acetylcholine (ACh) and nitroglycerine (GTN) were made via a 3F infusion catheter into the target artery. Following infusion, changes in diameter of segments proximal and distal to the PCI site were measured. Results: There was a significant impairment in endothelium-dependent dilatation at the maximal dose of acetylcholine in those with restenosis compared to those without restenosis, both proximal and distal to the stented area (proximal; 11.5 +/- 7.0% versus -20.9 +/- 9.0% p<0.001, distal; 12.0 +/- 3.1% versus -17.8 +/- 8.1% p<0.001), but there was no difference in the response to GTN. There was a significant correlation between the endothelium-dependent dilatation response and the percent restenosis (r=-0.65, p=0.003). Conclusions: Coronary endothelium-dependent dilatation is reduced in subjects with restenosis in arterial segments separate from the stented lesion. This supports a hypothesis that endothelial dysfunction contributes to the development of restenosis, following percutaneous coronary intervention. (C) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:362 / 367
页数:6
相关论文
共 50 条
  • [21] Endothelial Progenitor Cells and Percutaneous Coronary Artery Intervention
    Briguori, Carlo
    Quintavalle, Cristina
    Napolitano, Giovanni
    Condorelli, Gerolama
    CARDIOVASCULAR DRUGS AND THERAPY, 2015, 29 (02) : 105 - 106
  • [22] EVALUATION OF NEOPTERIN AS A MARKER FOR RESTENOSIS FOLLOWING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    EBER, B
    SCHUMACHER, M
    TATZBER, F
    KAUFMANN, P
    LUHA, O
    ESTERBAUER, H
    GASSER, R
    KLEIN, W
    CARDIOVASCULAR DRUGS AND THERAPY, 1995, 9 (02) : 361 - 362
  • [23] KETANSERIN PREVENTS EARLY RESTENOSIS FOLLOWING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    KLEIN, W
    EBER, B
    DUSLEAG, J
    ROTMAN, B
    KOLTRINGER, P
    LUHA, O
    VANHOUTTE, PM
    CLINICAL PHYSIOLOGY AND BIOCHEMISTRY, 1990, 8 : 101 - 107
  • [24] Metoprolol treatment to prevent restenosis following percutaneous transluminal coronary angioplasty
    Franzen, D
    Seifert, N
    Metha, A
    Höpp, HW
    CARDIOLOGY, 2002, 97 (02) : 94 - 98
  • [25] Quantitatively assessed coronary collateral circulation and restenosis following percutaneous revascularization
    Wahl, A
    Billinger, M
    Fleisch, M
    Meier, B
    Seiler, C
    EUROPEAN HEART JOURNAL, 2000, 21 (21) : 1776 - 1784
  • [26] Plasma Phospholipids and Sphingolipids Identify Stent Restenosis After Percutaneous Coronary Intervention
    Cui, Song
    Li, Kefeng
    Ang, Lawrence
    Liu, Jinghua
    Cui, Liqian
    Song, Xiantao
    Lv, Shuzheng
    Mahmud, Ehtisham
    JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (13) : 1307 - 1316
  • [27] Genetic risk factors for restenosis after percutaneous coronary intervention in Kazakh population
    Elena V. Zholdybayeva
    Yerkebulan A. Talzhanov
    Akbota M. Aitkulova
    Pavel V. Tarlykov
    Gulmira N. Kulmambetova
    Aisha N. Iskakova
    Aliya U. Dzholdasbekova
    Olga A. Visternichan
    Dana Zh. Taizhanova
    Yerlan M. Ramanculov
    Human Genomics, 10
  • [28] Altered autonomic cardiac control predicts restenosis after percutaneous coronary intervention
    Goernig, M
    Gramsch, M
    Baier, V
    Figulla, HR
    Leder, U
    Voss, A
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2006, 29 (02): : 188 - 191
  • [29] Clinical and angiographic factors associated with asymptomatic restenosis after percutaneous coronary intervention
    Ruygrok, PN
    Webster, MWI
    de Valk, V
    van Es, GA
    Ormiston, JA
    Morel, MAM
    Serruys, PW
    CIRCULATION, 2001, 104 (19) : 2289 - 2294
  • [30] Predicting the Restenosis Benefit of Drug-Eluting Versus Bare Metal Stents in Percutaneous Coronary Intervention
    Yeh, Robert W.
    Normand, Sharon-Lise T.
    Wolf, Robert E.
    Jones, Philip G.
    Ho, Kalon K. L.
    Cohen, David J.
    Cutlip, Donald E.
    Mauri, Laura
    Kugelmass, Aaron D.
    Amin, Amit P.
    Spertus, John A.
    CIRCULATION, 2011, 124 (14) : 1557 - +